Table 3.
Association of hyperglycaemia and diabetes with the time to death using stepwise Cox regression (n = 373).
Covariates | HR | 95% CI |
---|---|---|
Step 1: using 59 covariatesa | ||
Fatigue | 3.33 | 1.53–7.23 |
Dialysis | 2.95 | 1.21–7.22 |
Differential neutrophil countb | 1.05 | 1.01–1.08 |
Initial Serum globulin (g/L) | 2.25 | 1.32–3.84 |
Initial Platelet count (x109 cells/L) | 0.99 | 0.99–1.00 |
Steroids | 12.21 | 1.49–100.0 |
Step 2: Step 1 covariates + hyperglycaemia | ||
Hyperglycaemia | 5.56 | 1.62–19.0 |
Fatigue | 3.24 | 1.46–7.16 |
Age (y) | 1.03 | 1.01–1.06 |
Steroids | 13.88 | 1.64–117.65 |
Initial Serum globulin (g/L) | 2.15 | 1.31–3.50 |
Initial platelet count (x109 cells/L) | 0.99 | 0.99–1.00 |
Differential neutrophil countb(%) | 1.04 | 1.00–1.08 |
Marijuana use | 6.07 | 1.24–29.6 |
Rivaroxaban | 8.37 | 1.04–66.8 |
Step 3: Step 1 covariates + combination of diabetes and hyperglycaemia | ||
Glycaemic status | ||
No-diabetes/no-hyperglycaemia | Ref | |
No-diabetes/hyperglycaemia | 8.86 | 1.90–41.4 |
Diabetes/no-hyperglycaemia | 10.6 | 0.85–131.8 |
Diabetes/hyperglycaemia | 7.58 | 1.73–33.1 |
Fatigue | 3.41 | 1.49–7.80 |
Age (y) | 1.04 | 1.01–1.06 |
Steroids | 16.0 | 1.83–139.8 |
Initial Serum globulin (g/L) | 2.26 | 1.41–3.60 |
Initial Platelet count (x109 cells/L) | 0.99 | 0.99–1.00 |
Differential neutrophil countb(%) | 1.04 | 1.01–1.07 |
Marijuana use | 5.19 | 0.99–160.5 |
Rivaroxaban | 9.63 | 1.19–78.3 |
HR, hazards ratio; CI, confidence interval; Ref, reference category.
Abbreviations: % — percentage, y — years, g/L — grams per Litre, L — Litre.
Results are from the final model retained after stepwise forward addition strategy. The full list of included variables in given in the Methods section. Variables in the final model are shown in the order of entry into the model.
used as a continuous variable and expressed as percentage.